Podcast #70: The FDA and Caution vs Innovation

Jordan Reimschisel joins the podcast today to talk about his recent piece in RealClearHealth regarding the FDA and slowing medical innovation. He argues that the process of the FDA is based off a warped incentive structure that places excessive caution ahead of innovation that could save lives.

Follow Jordan @JTRimschisel and Young Voices on Twitter @yvadv and Stephen Kent @stephenofkent

Leave us a review on iTunes, Stitcher or GooglePlay where this podcast can be found and email [email protected] with your thoughts on the show.

Comments are closed.